Blood Reviews
Volume 22, Issue 1 , Pages 17-31 , January 2008

Hemolytic anemia due to warm autoantibodies

References 

  1. Packman C. Historical Review: The Spherocytic Haemolytic Anaemias. Br J Haematol. 2003;112:888–899
  2. Coombs RRA, Mourant AE, Race EE. Detection of weak and “incomplete” Rh agglutinins: A new test. Lancet ii. 1945;246:15–16
  3. Moreschi C. Neue tatsachen uber blutkorperchenagglutination. Zentralbl Bacteriol Parasitenkd Infektkr Originale. 1908;46:49–51
  4. Coombs RRA, Mourant AE, Race RR. A new test for the detection of weak and ‘incomplete’ Rh agglutinins. British Journal of Experimental Pathology. 1945;26:255–266
  5. Boorman KE, Dodd BE, Loutit JF. Haemolytic icterus (acholuric jaundice), congenital and acquired. Lancet. 1946;1:812–814
  6. Loutit JF, Mollison PL. Haemolytic icterus (acholuric jaundice), congenital and acquired. J Pathol Bacteriol. 1946;58:711–728
  7. Petz LD, Garratty G. Acquired Immune Hemolytic Anemias. London: Churchill Livingstone; 1980;
  8. Pirofsky B. Hereditary aspects of autoimmune hemolytic anemia: A retrospective analysis. Vox Sang. 1968;14:334–347
  9. Dobbs CE. Familial auto-immune hemolytic anemia. Arch Intern Med. 1965;116:273–276
  10. Cordova MS, Baez-Villasenor J, Mendez JJ, Campos E. Acquired hemolytic anemia with positive antiglobulin (Coombs’ test) in mother and daughter. Arch Intern Med. 1966;117:692–695
  11. Dacie JV. The Haemolytic Anaemias. In: 3d ed.. The Autoimmune Haemolytic Anaemias. vol. 3:New York: Churchill Livingstone; 1992;
  12. Sokol RJ, Hewitt S, Stamps BK. Autoimmune haemolysis: An 18 year study of 865 cases referred to a regional transfusion centre. Br Med J. 1981;282:2023–2027
  13. Sokol RJ, Hewitt S, Stamps BK. Autoimmune haemolysis: Mixed warm and cold antibody type. Acta Haematol. 1983;69:266–274
  14. Shulman IA, Branch DR, Nelson JM, Thompson JC, Saxena S, Petz LD. Autoimmune hemolytic anemias with both cold and warm autoantibodies. JAMA. 1985;253:1746–1748
  15. Kajii E, Miura Y, Ikemoto S. Characterization of autoantibodies in mixed-type autoimmune hemolytic anemia. Vox Sang. 1991;60:45–52
  16. Berentsen S, Bo K, Shammas F, Myking A, Ulvestad E. Chronic cold agglutinin disease of the “idiopathic” type is a premalignant or low-grade malignant lymphoproliferative disease. APMIS. 1997;105:354–362
  17. Telen MJ, Roberts KB, Bartlett JA. HIV-associated autoimmune hemolytic anemia: Report of a case and review of the literature. J Acquir Immune Defic Syndr. 1990;3:933–937
  18. Rapoport AP, Rowe JM, McMican A. Life-threatening autoimmune hemolytic anemia in patient with acquired immune deficiency syndrome. Transfusion. 1988;28:190–191
  19. Saif M. HIV Associated Autoimmune Hemolytic Anemia: An Update. AIDS Patient Care. 2001;15:217–224
  20. Habibi B, Basty R, Chodez S, Prunat A. Thiopental-related immune hemolytic anemia and renal failure. N Engl J Med. 1985;312:353–355
  21. Habibi B. Drug-induced red blood cell autoantibodies co-developed with drug-specific antibodies causing a hemolytic anaemia. Br J Haematol. 1985;61:139–143
  22. Sosler SD, Behzad O, Garratty G, Lee CL, Postanay N, Khomo O. Acute hemolytic anemia associated with a chlorpropamide-induced apparent auto-anti-Jka. Transfusion. 1984;24:206–209
  23. Salama A, Mueller-Eckhardt C. Rh blood group-specific antibodies in immune hemolytic anemia induced by nomifensine. Blood. 1986;68:1285–1288
  24. Salama A, Mueller-Eckhardt C. On the mechanisms of sensitization and attachment of antibodies to RBC in drug-induced immune hemolytic anemia. Blood. 1987;69:1006–1010
  25. Arndt P, Garratty G. Cross-Reactivity of cefotetan and ceftriaxone antibodies, associated with hemolytic anemia, with other cephalosporins and penicillin. Am J Clin Pathol. 2002;118:256–2002
  26. Weiss R, Freiman J, Kweder S, Diehl LF, Byrd JC. Hemolytic anemia after fludarabine therapy for chronic lymphocytic leukemia. J Clin Oncol. 1998;16:1885–1889
  27. Chasty RC, Myint H, Oscier DG, Orchard JA, Bussutil DP, Hamon MD. Autoimmune haemolysis in patients with B-CLL treated with chlorodeoxyadenosine (CDA). Leuk Lymphoma. 1998;29:391–398
  28. Worlledge SM. Immune drug-induced haemolytic anaemias. Semin Hematol. 1969;6:181–200
  29. Leddy JP, Falany JL, Kissel GE, Passodor ST, Rosenfeld SI. Erythrocyte membrane proteins reactive with human (warm-reacting) anti-red cell autoantibodies. J Clin Invest. 1993;91:1672–1680
  30. Mollison PL. Measurement of survival and destruction of red cells in haemolytic syndromes. Br Med Bull. 1959;15:59–67
  31. Crowley LV, Bouroncle BA. Studies on the specificity of autoantibodies in acquired hemolytic anemia. Blood. 1956;11:700–707
  32. Chaplin H, Cohen R, Bloomberg G, Kaplan HJ, Moore JA, Dorner I. Pregnancy and idiopathic autoimmune haemolytic anaemia: A prospective study during 6 months gestation and 3 months “post-partum”. Br J Haematol. 1973;24:219–229
  33. Mollison PL, Crome P, Hughes-Jones NC, Rochna E. Rate of removal from the circulation of red cells sensitized with different amounts of antibody. Br J Haematol. 1965;11:461–470
  34. Mollison PL, Hughes-Jones NC. Clearance of Rh-positive red cells by low concentration of Rh antibody. Immunology. 1967;12:63–73
  35. Rosse WF. Quantitative immunology of immune hemolytic anemia: II. The relationship of cell-bound antibody to hemolysis and the effect of treatment. J Clin Invest. 1971;50:734–743
  36. Schreiber AD, Frank MM. Role of antibody and complement in the immune clearance and destruction of erythrocytes: I. In vivo effects of IgG and IgM complement-fixing sites. J Clin Invest. 1972;51:575–582
  37. Atkinson JP, Schreiber AD, Frank MM. Effects of corticosteroids and splenectomy on the immune clearance and destruction of erythrocytes. J Clin Invest. 1973;52:1509–1517
  38. Atkinson JP, Frank MM. Complement independent clearance of IgG sensitized erythrocytes: Inhibition by cortisone. Blood. 1974;44:629–637
  39. Jandl JH, Richardson-Jones A, Castle WB. The destruction of red cells by antibodies in man: I. Observations on the sequestration and lysis of red cells altered by immune mechanisms. J Clin Invest. 1957;36:1428–1459
  40. Jandl JH, Kaplan ME. The destruction of red cells by antibodies in man: III. Quantitative factors influencing the pattern of hemolysis in vivo. J Clin Invest. 1960;39:1145–1156
  41. Anderson CL, Looney RJ. Human leukocyte IgG Fc receptors. Immunol Today. 1986;7:264
  42. Ravetch JV, Kinet J-P. Fc receptors. Annu Rev Immunol. 1991;9:457–492
  43. Gigli I, Nelson RA. Complement-dependent immune phagocytosis: I. Requirements of C1, C4, C2, C3. Exp Cell Res. 1968;51:45–67
  44. Lay WF, Nussenzweig V. Receptors for complement on leukocytes. J Exp Med. 1968;128:991–1009
  45. Ross GD. Opsonization and membrane complement receptors. In:  Ross GD editors. Immunobiology of the Complement System. Orlando: Academic Press; 1986;p. 87
  46. Fischer JT, Petz LD, Garratty G, Cooper NR. Correlations between quantitative assay of red cell bound C3, serologic reactions, and hemolytic anemia. Blood. 1974;44:359–373
  47. Schreiber AD, Parsons J, McDermott P, Cooper RA. Effect of corticosteroids on the human monocyte IgG and complement receptors. J Clin Invest. 1975;56:1189–1197
  48. Ehlenberger AG, Nussenzweig V. The role of membrane receptors for C3b and C3d in phagocytosis. J Exp Med. 1977;145:357–371
  49. Abramson N, LoBuglio AF, Jandl JH, Cotran RS. The interaction between human monocytes and red cells: Binding characteristics. J Exp Med. 1970;132:1191–1206
  50. LoBuglio AF, Cotran RS, Jandl JH. Red cells coated with immunoglobulin G: Binding and sphering by mononuclear cells in man. Science. 1967;158:1582–1585
  51. Rosse WF, de Boisfleury A, Bessis M. The interaction of phagocytic cells and red cells modified by immune reactions: Comparison of antibody and complement coated red cells. Blood Cells. 1975;1:345–358
  52. Dameshek W, Schwartz SO. Acute hemolytic anemia (acquired hemolytic icterus, acute type). Medicine. 1940;19:231–327
  53. Leddy JP, Rosenfeld SI. Role of complement in hemolytic anemia and thrombocytopenia. In:  Ross GD editors. Immunobiology of the Complement System. Orlando: Academic Press; 1986;p. 213
  54. Evans RS, Duane RT. Acquired hemolytic anemia: I. The relation of erythrocyte antibody production to activity of the disease. II. The significance of thrombocytopenia and leukopenia. Blood. 1949;4:1196–1213
  55. Evans RS, Takahashi K, Duane RT, Payner R, Liu C. Primary thrombocytopenic purpura and acquired hemolytic anemia: Evidence for a common etiology. Arch Intern Med. 1951;87:48–65
  56. Pegels JG, Helmerhorst FM, vanLeeuwen EF, van de Plas-van Dalen C, Engelfriet CP, von dem Borne AE. The Evans syndrome: Characterization of the responsible autoantibodies. Br J Haematol. 1982;51:445–450
  57. Liesveld JL, Rowe JM, Lichtman MA. Variability of the erythropoietic response in autoimmune hemolytic anemia: Analysis of 109 cases. Blood. 1987;69:820–826
  58. Hegde UM, Gordon-Smith EC, Worlledge SM. Reticulocytopenia and absence of red cell autoantibodies in immune haemolytic anaemia. Br Med J. 1977;2:1444–1447
  59. Conley CL, Lippman SM, Ness P. Autoimmune hemolytic anemia with reticulocytopenia: A medical emergency. JAMA. 1980;244:1688–1690
  60. Greenberg J, Curtis-Cohen M, Gill FM, Cohen A. Prolonged reticulocytopenia in autoimmune hemolytic anemia of childhood. J Pediatr. 1980;97:784–786
  61. Eyster ME, Jenkins DE. Erythrocyte coating substances in patients with positive direct antiglobulin reactions: Correlation of γG globulin and complement coating with underlying diseases, overt hemolysis and response to therapy. Am J Med. 1969;46:360–371
  62. Leddy JP. Immunological aspects of red cell injury in man. Semin Hematol. 1966;l 3:48–73
  63. Engelfriet CP, von dem Borne AEG Kr, Vander Giessen M, Beckers D, van Loghem JJ. Autoimmune haemolytic anaemias: I. Serological studies with pure anti-immunoglobulin reagents. Clin Exp Immunol. 1968;3:605–614
  64. Engelfriet CP, von dem Borne AEG Kr, Beckers D, van Loghem JJ. Autoimmune haemolytic anaemia: Serological and immunochemical characteristics of the autoantibodies: Mechanisms of cell destruction. Ser Haematol. 1974;7:328–347
  65. Suzuki S, Amano T, Mitsunaga M, Yagyu F, Ofuji T. Autoimmune hemolytic anemia associated with IgA autoantibody. Clin Immunol Immunopathol. 1981;21:247–256
  66. Wolf CF, Wolf DJ, Peterson P, Brandstetter RD, Hansen DE. Autoimmune hemolytic anemia with predominance of IgA autoantibody. Transfusion. 1982;22:238–240
  67. Szymanski IO, Teno R, Rybak ME. Hemolytic anemia due to a mixture of low-titer IgG lambda and IgM lambda agglutinins reacting optimally at 22°C. Vox Sang. 1986;51:112–116
  68. Reusser P, Osterwalder B, Burri H, Speck B. Autoimmune hemolytic anemia associated with IgA: Diagnostic and therapeutic aspects in a case with long-term follow-up. Acta Haematol. 1987;77:53–56
  69. Göttsche B, Salama A, Mueller-Eckhardt C. Autoimmune hemolytic anemia associated with an IgA autoanti-Gerbich. Vox Sang. 1990;58:211–214
  70. Evans RS, Bingham M, Boehni P. Autoimmune hemolytic disease: Antibody dissociation and activity. Arch Intern Med. 1961;108:338–352
  71. Evans RS, Bingham M, Turner E. Autoimmune hemolytic disease: Observations of serological reactions and disease activity. Ann NY Acad Sci. 1965;124:422–440
  72. Gilliland BC, Leddy JP, Vaughan JH. The detection of cell-bound antibody on complement-coated human red cells. J Clin Invest. 1970;49:898–906
  73. Gilliland BC, Baxter E, Evans RS. Red cell antibodies in acquired hemolytic anemia with negative antiglobulin serum tests. N Engl J Med. 1971;285:252–256
  74. Gilliland BC. Coombs-negative immune hemolytic anemia. Semin Hematol. 1976;13:267–275
  75. Sokol RJ, Hewitt S, Booker DJ, Bailey A. Erythrocyte autoantibodies, subclasses of IgG and autoimmune haemolysis. Autoimmunity. 1990;6:99–104
  76. von dem Borne AE Kr, Beckers D, van der Meulen W, Engelfriet CP. IgG4 autoantibodies against erythrocytes, without increased hemolysis: A case report. Br J Haematol. 1977;37:137–144
  77. Issitt PD, Pavone BG, Goldfinger D, Zwikder H, Issit CH, Tessel JA. Anti-Wrb and other autoantibodies responsible for positive direct antiglobulin test in 150 individuals. Br J Haematol. 1976;34:5–18
  78. Weiner W, Vos GH. Serology of acquired hemolytic anemia. Blood. 1963;22:606–613
  79. Vos GH, Petz L, Funenberg HH. Specificity of acquired haemolytic anaemia autoantibodies and their serological characteristics. Br J Haematol. 1970;19:57–66
  80. Leddy JP, Peterson P, Yeaw MA, Bakemeier RF. Patterns of serologic specificity of human γG erythrocyte autoantibodies. J Immunol. 1970;105:677–686
  81. Barker RN, Casswell KM, Reid ME, Sokol RJ, Elson CJ. Identification of autoantigens in autoimmune haemolytic anaemia by a non-radioisotope immunoprecipitation method. Br J Haematol. 1992;82:126–132
  82. Bell CA, Zwicker H. Further studies on the relationship of anti-Ena and anti-Wrb in warm autoimmune hemolytic anemia. Transfusion. 1978;18:572–575
  83. Celano MJ, Levine P. Anti-LW specificity in autoimmune acquired hemolytic anemia. Transfusion. 1967;7:265–268
  84. Marsh WL, Reid ME, Scott EP. Autoantibodies of U blood group specificity in autoimmune haemolytic anaemia. Br J Haematol. 1972;22:625–629
  85. Shulman IA, Vengelen-Tyler V, Thompson JC, Nelson JM, Chen DC. Autoanti-Ge associated with severe autoimmune hemolytic anemia. Vox Sang. 1990;59:232–234
  86. Owen I, Chowdhury V, Reid ME, Poole J, Marsh JC, Hows JM. Autoimmune hemolytic anemia associated with anti-Sc1. Transfusion. 1992;32:173–176
  87. Marsh WL, Oyen R, Alicea E, Linter M, Horton S. Autoimmune hemolytic anemia and the Kell blood groups. Am J Hematol. 1979;7:155–162
  88. Victoria EJ, Pierce SW, Branks MJ, Masouredis SP. IgG red blood cell autoantibodies in autoimmune hemolytic anemia bind to epitopes on red blood cell membrane band 3 glycoprotein. J Lab Clin Med. 1990;115:74–88
  89. Telen MJ, Chasis JA. Relationship of the human erythrocyte Wrb antigen to an interaction between glycophorin A and band 3. Blood. 1990;76:842–848
  90. Lichtman MA, Beutler E, Kipps T, Seligsohn U, Kaushansky K. Prchal. In: Williams Hematology. New York: McGraw Hill; 2005;
  91. Sokol R, Stamps R, Booker D, Scott FM, Ladlaw ST, Vandenberghe EA. Posttransplant immune-mediated hemolysis. Transfusion. 2002;42:198–204
  92. Lundgren G, Asaba H, Bergström J, Groth CG, Magnusson G, Moller E. Fulminating anti-A autoimmune hemolysis with anuria in a renal transplant recipient: A therapeutic role of plasma exchange. Clin Nephrol. 1981;16:211–214
  93. Ramsey G, Nusbacher J, Starzl TE, Lindsay GD. Isohemagglutinins of graft origin after ABO-unmatched liver transplantation. N Engl J Med. 1984;311:1167–1170
  94. Mangal AK, Growe GH, Sinclair M, Stillwell GF, Reeve CE, Naiman SC. Acquired hemolytic anemia due to “auto”-anti-a or “auto”-anti-b induced by group O homograft in renal transplant recipients. Transfusion. 1984;24:201–205
  95. Hazlehurst GR, Brenner MK, Wimperis JZ, Knowles Sm, Prentice HG. Haemolysis after T-cell depleted bone marrow transplantation involving minor ABO incompatibility. Scand J Haematol. 1986;37:1–3
  96. Solheim BG, Albrechtsen D, Egeland T, Flatmark A, Fauchald P, Froysaker T. Auto-antibodies against erythrocytes in transplant patients produced by donor lymphocytes. Transplant Proc. 1987;6:4520–4521
  97. Sniecinski IJ, Oien L, Petz LD, Blume KG. Immunohematologic consequences of major ABO-mismatched bone marrow transplantation. Transplantation. 1988;45:530–534
  98. Issitt PD. Autoimmune hemolytic anemia and cold hemagglutinin disease: Clinical disease and laboratory findings. Prog Clin Pathol. 1978;7:137–163
  99. Wallhermfechtel MA, Pohl BA, Chaplin H. Alloimmunization in patients with warm autoantibodies. A retrospective study employing three donor alloabsorptions to aid in antibody detection. Transfusion. 1984;24:482–485
  100. Branch DR, Petz LD. Detecting alloantibodies in patients with autoantibodies. Transfusion. 1999;39:6–10
  101. Greendyke RM, Bradley EB, Swisher SN. Studies of the effects of administration of ACTH and adrenal corticosteroids on erythrophagocytosis. J Clin Invest. 1965;44:746–753
  102. Fries LF, Brickman CM, Frank MM. Monocyte receptors for the Fc portion of IgG increase in number in autoimmune hemolytic anemia and other hemolytic states and are decreased by glucocorticoid therapy. J Immunol. 1983;131:1240–1245
  103. Allgood JW, Chaplin HJ. Idiopathic acquired autoimmune hemolytic anemia: A review of forty-seven cases treated from 1955 to 1965. Am J Med. 1967;43:254–273
  104. Meyer O, Stahl D, Beckhove P, Huhn D, Salama A. Pulsed high-dose dexamethasone in chronic autoimmune haemolytic anaemia of warm type. Br J Haemotal. 1997;98:860–862
  105. Habibi B, Homberg JC, Schaison G, Salmon C. Autoimmune hemolytic anemia in children: A review of 80 cases. Am J Med. 1974;56:61–69
  106. Christensen BE. The pattern of erythrocyte sequestration in immunohaemolysis: Effects of prednisone treatment and splenectomy. Scand J Haematol. 1973;10:120–129
  107. Parker AC, MacPherson AIS, Richmond J. Value of radiochromium investigation in autoimmune haemolytic anemia. Br Med J. 1977;1:208–209
  108. Bowdler AJ. The role of the spleen and splenectomy in autoimmune hemolytic disease. Semin Hematol. 1976;13:335–348
  109. Schwartz SI, Bernard RP, Adams JT, Bauman AW. Splenectomy for hematologic disorders. Arch Surg. 1970;101:338–347
  110. Eichner ER. Splenic function: Normal, too much and too little. Am J Med. 1979;66:311320
  111. Newland A, Provan D. Preventing severe infection after splenectomy. Brit Med J. 2005;331:20–27
  112. Centers for Disease Control and Prevention: Recommended adult immunization schedule-United States, 2003-2004. MMWR 2003; 52:965–969.
  113. Zecca M, Nobili B, Ramenghi U, Perrotta S, Amendola G, Rosito P. Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. Blood. 2003;101:3857–3861
  114. Murphy S, LoBuglio AF. Drug therapy of autoimmune hemolytic anemia. Semin Hematol. 1976;13:323–334
  115. Moyo VM, Smith D, Brodsky I, Crilley P, Jones RJ, Brodsky RA. High-dose cyclophosphamide for refractory autoimmune hemolytic anemia. Blood. 2002;100:704–706
  116. Emilia C, Messora C, Longo G, Bertesi M. Long-term salvage treatment by cyclosporine in refractory autoimmune haematological disorders. Br J Haematol. 1996;93:341–344
  117. Howard J, Hoffbrand AV, Prentice HG, Mehta A. Mycophenolate mofetil for the treatment of refractory auto-immune haemolytic anaemia and auto-immune thrombocytopenic purpura. Br J Haematol. 2002;117:712–715,
  118. Fibich C, Schober C, Schmoll H-J. Treatment of refractory autoimmune hemolytic anemias with mycophenolate-mofetil (Cellcept) [abstract}. Br J Haematol. 1998;102:39
  119. Shumak KH, Rock GA. Therapeutic plasma exchange. N Engl J Med. 1984;310:762–771
  120. Council Report: Current status of therapeutic plasmapheresis and related techniques. JAMA 1985; 253:819–825.
  121. Flores G, Cunningham-Rundles C, Newland AC, Bussel JB. Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: Results in 73 patients. Am J Hematol. 1993;44:237–242
  122. Ahn YS, Harrington WJ, Mylvaganam R, Ayub j, Pall LM. Danazol therapy for autoimmune hemolytic anemia. Ann Intern Med. 1985;102:298–301
  123. Pignon J-M, Poirson E, Rochant H. Danazol in autoimmune haemolytic anaemia. Br J Haematol. 1993;83:343–345
  124. Giannadaki E, Potamianos S, Roussomoustakaki M, Kyriakou D, Fragkiadakis SN, Manousos ON. Autoimmune hemolytic anemia and positive Coombs test associated with ulcerative colitis. Am J Gastroenterol. 1997;92:1872–1874
  125. Cobo F, Pereira A, Nomdedeu B, Gallart T, Ordi J, Torne A. Ovarian dermoid cyst- associated autoimmune hemolytic anemia. Am J Clin Pathol. 1996;105:567–571
  126. Sallah S, Wan J, Hanrahan L. Future development of lymphoproliferative disorders in patients with autoimmune hemolytic anemia. Clin Cancer Res. 2001;7:791–794
  127. Dausset J, Colombani J. The serology and the prognosis of 128 cases of autoimmune hemolytic anemia. Blood. 1959;14:1280–1301
  128. Pullarkat V, Ngo M, Iqbal S, Espina B, Liebman HA. Detection of lupus anticoagulant identifies patients with autoimmune haemolytic anaemia at increased risk of venous thromboemoblism. Brit J Haematol. 2002;118:1166–1169
  129. Hendrick AM. Auto-immune haemolytic anaemia – a high-risk disorder for thromboembolism?. Hematology. 2003;8:53–56

PII: S0268-960X(07)00050-1

doi: 10.1016/j.blre.2007.08.001

Blood Reviews
Volume 22, Issue 1 , Pages 17-31 , January 2008

Article Tools

* Image Usage & Resolution